Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Wang ZY, Liu YY, Liu GH, Lu HB, Mao CY (2018) L-carnitine and heart disease
LiverTox NCBI Bookshelf
Collectively, these microbiota-modulating therapies offer a diverse therapeutic entry point capable of changing metabolic, immunological, and neurotrophic pathways involved in PD development [167, 168]
The goal is to eat in a way that supports your body while your appetite, digestion, and food preferences may be changing
Metabolic reprogramming in cancer: Mechanisms and therapeutics
The USA shows growth at 5.2%, reflecting a mature healthcare market but strong demand for advanced treatments
US$ 21.84
US$ 26.82
US$ 20.91
US$ 2249.50
Sold : Login>>